Primary brain tumors, neural stem cell, and brain tumor cancer cells: Where is the link?

Neuropharmacology

Volumn 58, Issue 6, 2010, Pages 903-910

  Germano, Isabelle ^a   Swiss, Victoria ^a   Casaccia, Patrizia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Epigenetics; Glioblastoma; Proliferation; Stem cells

Indexed keywords

CARBOPLATIN; CARMUSTINE; CD133 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOPAMINE; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; HOX PROTEIN; KRUPPEL LIKE FACTOR 4; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PACLITAXEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN MDM2; PROTEIN P53; RAS PROTEIN; RETINOBLASTOMA PROTEIN; SONIC HEDGEHOG PROTEIN; TEMOZOLOMIDE; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNINDEXED DRUG;

ASTROCYTE; ASTROCYTOMA; BRAIN CANCER; BRAIN SURGERY; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE REGULATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; MALIGNANT TRANSFORMATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN NEOPLASMS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GLIOMA; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; NEURONS; STEM CELLS;

EID: 77649338990     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.12.019     Document Type: Review

References (118)

1. Abdouh M., Facchino S., Chatoo W., Balasingam V., Ferreira J., and Bernier G. BMI1 sustains human glioblastoma multiforme stem cell renewal. J. Neurosci. 29 (2009) 8884-8896
2. Ahn S., and Joyner A.L. In vivo analysis of quiescent adult NSCs responding to sonic hedgehog. Nature 437 7060 (2005) 894-897
3. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3983-3988
4. Altman J., and Das G.D. Autoradiographic examination of the effects of enriched environment on the rate of glial multiplication in the adult rat brain. Nature 204 (1964) 1161-1163
5. Alonso M.M., Fueyo J., Shay J.W., Aldape K.D., Jiang H., Lee O.H., Johnson D.G., Xu J., Kondo Y., Kanzawa T., Kyo S., Bekele B.N., Zhou X., Nigro J., McDonald J.M., Yung W.K., and Gomez-Manzano C. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J. Natl. Cancer Inst. 97 21 (2005) 1589-1600
6. Arifin M.T., Hama S., Kajiwara Y., Sugiyama K., Saito T., Matsuura S., Yamasaki F., Arita K., and Kurisu K. Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas. J. Neurooncol. 77 3 (2006) 273-277
7. Assanah M., Lochhead R., Ogden A., Bruce J., Goldman J., and Canoll P. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J. Neurosci. 26 25 (2006) 6781-6790
8. Babaie Y., Herwig R., Greber B., Brink T.C., Wruck W., Groth D., Lehrach H., Burdon T., and Adjaye J. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells 25 2 (2007) 500-510
9. Bachoo R.M., Maher E.A., Ligon K.L., et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1 (2002) 269-277
10. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., and Hjelmeland A.B. Glioma stem cells promote radioresistance. Nature 444 (2006) 756-760
11. Bar E.E., Chaudhry A., Lin A., Fan X., Schreck K., Matsui W., Piccirillo S., Vescovi A.L., DiMeco F., Olivi A., and Eberhart C.G. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 25 10 (2007) 2524-2533
12. Becher O.J., Hambardzumyan D., Fomchenko E.I., Momota H., Mainwaring L., Bleau A.M., Katz A.M., Edgar M., Kenney A.M., Cordon-Cardo C., Blasberg R.G., and Holland E.C. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Res. 68 7 (2008) 2241-2249
13. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., and Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67 9 (2007) 4010-4015
14. Blum R., Nakdimon I., Goldberg L., Elkon R., Shamir R., Rechavi G., and Kloog Y. E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell-cycle arrest in response to Ras inhibition. Int. J. Cancer 119 3 (2006) 527-538
15. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
16. Bouvier C., Bartoli C., Aguirre-Cruz L., Virard I., Colin C., Fernandez C., Gouvernet J., and Figarella-Branger D. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells. J. Neurosurg. 99 (2003) 344-350
17. Brada M., Hoang-Xuan K., Rampling R., Dietrich P.Y., Dirix L.Y., and Macdonald D. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann. Oncol. 12 (2001) 259-266
18. Bruggeman S.W., Valk-Lingbeek M.E., van der Stoop P.P., Jacobs J.J., Kieboom K., Tanger E., Hulsman D., Leung C., Arsenijevic Y., Marino S., and van Lohuizen M. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev. 19 12 (2005) 1438-1443
19. Card D.A., Hebbar P.B., Li L., Trotter K.W., Komatsu Y., Mishina Y., and Archer T.K. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol. Cell Biol. 28 20 (2008) 6426-6438
20. CBTRUS, Statistical report: Primary Brain Tumors in the United States, 2000-2004, 2008.
21. Cheng J.X., Liu B.L., and Zhang X. How powerful is CD133 as a cancer stem cell marker in brain tumors?. Cancer Treat. Rev. 35 (2009) 403-408
22. Chivukula R.R., and Mendell J.T. Abate and switch: miR-145 in stem cell differentiation. Cell 137 4 (2009) 606-608
23. Clement V., Sanchez P., de Tribolet N., Radovanovic I., and Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 17 2 (2007 Jan 23) 165-172
24. Dahlstrand J., Collins V.P., and Lendahl U. Expression of the class VI intermediate filament nestin in human center nervous system tumors. Cancer Res. 52 (1992) 5334-5341
25. Dey, M., Ulasov, I.V., Lesniak, M.S. Virotherapy against malignant glioma stem cells. Cancer Lett., in press.
26. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., and Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97 (1999) 703-716
27. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr. C.A., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 6366 (1992) 215-221
28. Du Z., Jia D., Liu S., Wang F., Li G., Zhang Y., Cao X., Ling E.A., and Hao A. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia 57 7 (2009) 724-733
29. Ehtesham M., Sarangi A., Valadez J.G., Chanthaphaychith S., Becher M.W., Abel T.W., Thompson R.C., and Cooper M.K. Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene 26 39 (2007) 5752-5761
30. Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., and Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51 (1991) 2164-2172
31. Ellis P., Fagan B.M., Magness S.T., Hutton S., Taranova O., Hayashi S., McMahon A., Rao M., and Pevny L. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev. Neurosci. 26 2-4 (2004) 148-165
32. Eramo A., Ricci-Vititani L., Zeuner A., Pallini R., Lotti F., and Sette G. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ. 13 (2006) 1238-1241
33. Esposito I., Kleeff J., Bischoff S.C., Fuscher L., Collecchi P., Iorio M., Bevilacqua G., Buchler M.W., and Friess H. The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab. Invest. 82 (2002) 1481-1492
34. Fargeas C.A., Huttner W.B., and Corbeil D. Nomenclature of prominin-1 (CD133) splice variants - an update. Tissue Antigens 69 (2007) 602-606
35. Favaro, R., Valotta, M., Ferri, A.L.M., Latorre, E., Mariani, J., Giachino, C., Lancini, C., Tosetti, V., Ottolenghi, S., Taylor, V., Nicolis, S., 2009. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat. Neurosci. 12 (10), 1248-1256.
36. Fong H., Hohenstein K.A., and Donovan P.J. Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells 26 8 (2008) 1931-1938
37. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., DeVitis S., Fiocco R., Foroni C., Dimenco F., and Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64 (2004) 7011-7021
38. Gangemi R.M., Griffero F., Marubbi D., Perera M., Capra M.C., Malatesta P., Ravetti G.L., Zona G.L., Daga A., and Corte G. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27 1 (2009) 40-48
39. Gil-Perotin S., Verdugo J.M., Li J., Marin-Husstege M., Soriano-Navarro M., Zindy F., Roussel M., and Casaccia-Bonnefil P. Loss of p53 induces changes in the behaviour of subventricular zone cells: implications for the genesis of glial tumors. J. Neurosci. 26 (2006) 1107-1116
40. Goldman S.A., and Nottebohm F. Neuronal production, migration, and differentiation in a vocal control nucleus of the adult female canary brain. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 2390-2394
41. Hatton B.A., Knoepfler P.S., Kenney A.M., Rowitch D.H., de Alborán I.M., Olson J.M., and Eisenman R.N. N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res. 66 17 (2006) 8655-8661
42. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser K., and Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15178-15183
43. Hesselager G., Uhrbom L., Westermark B., and Nistér M. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res. 63 15 (2003) 4305-4309
44. Hidaka T., Hama S., Shrestha P., Saito T., Kajiwara Y., Yamasaki F., Sugiyama K., and Kurisu K. The combination of low cytoplasmic and high nuclear expression of p27 predicts a better prognosis in high-grade astrocytoma. Anticancer Res. 29 2 (2009 Feb) 597-603
45. Hilton D.A., Penney M., Pobereskin L., Sanders H., and Love S. Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival. Histopathology 44 6 (2004 Jun) 555-560
46. Hilton D.A., Penney M., Evans B., Sanders H., and Love S. Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival. Am. J. Surg. Pathol. 26 4 (2002) 472-478
47. Holland E.C., Celestino J., Dai C., Schaefer L., Sawaya R.E., and Fuller G.N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet. 25 (2000) 55-57
48. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., and Steindler V.A. Human cortical glial tumors contain neural stem-like cells expressing atroglial and neuronal markers in vitro. Glia 39 (2002) 193-206
49. Jiang J., Chan Y.S., Loh Y.H., Cai J., Tong G.Q., Lim C.A., Robson P., Zhong S., and Ng H.H. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat Cell Biol. 10 3 (2008) 353-360
50. Johansson C.B., Momma S., Clarke D.L., Risling M., Lendahl U., and Frisen J. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96 (1999) 25-34
51. Joo K.M., Kim S.Y., and Jiin X. Clinical and biological implications of CD133 positive and CD133 negative cells in glioblastomas. Lab. Invest. 88 (2008) 808-815
52. Kanamori M., Kawaguchi T., Nigro J.M., Feuerstein B.G., Berger M.S., Miele L., and Pieper R.O. Contribution of Notch signaling activation to human glioblastoma multiforme. J. Neurosurg. 106 3 (2007) 417-427
53. Kang M.K., and Kang S.K. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 16 (2007) 837-847
54. Katayama K., Ueno M., Yamauchi H., Nagata T., Nakayama H., and Doi K. Ethylnitrosourea induces neural progenitor cell apoptosis after S-phase accumulation in a p53-dependent manner. Neurobiol. Dis. 18 (2005) 218-225
55. Kelly J.J., Stechishin O., Chojnacki A., Lun X., Sun B., Senger D.L., Forsyth P., Auer R.N., Dunn J.F., Cairncross J.G., Parney I.F., and Weiss S. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cell 27 8 (2009) 1722-1733
56. Kirla R.M., Haapasalo H.K., Kalimo H., and Salminen E.K. Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer 97 3 (2003) 644-648
57. Kong D.S., Kim M.H., Park W.Y., Suh Y.L., Lee J.I., Park K., Kim J.H., and Nam D.H. The progression of gliomas is associated with cancer stem cell phenotype. Oncol. Rep. 19 3 (2008) 639-643
58. Lantos P.L., and Pilkington G.J. The development of experimental brain tumours. A sequential light and electron microscope study of the subependymal plate. I. Early lesions (abnormal cell clusters). Acta Neuropathol. (Berl.) 45 (1979) 167-175
59. Laurent L.C., Chen J., Ulitsky I., Mueller F.J., Lu C., Shamir R., Fan J.B., and Loring J.F. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells 26 6 (2008) 1506-1516
60. Leonard J.R., D'Sa C., Klocke B.J., and Roth K.A. Neural precursor cell apoptosis and glial tumorigenesis following transplacental ethyl-nitrosourea exposure. Oncogene 20 (2001) 8281-8286
61. Li L., Dutra A., Pak E., Labrie III J.E., Gerstein R.M., Pandolfi P.P., Recht L.D., and Ross A.H. EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors. Neuro-Oncol. 11 1 (2009 Feb) 9-21
62. Liu G., Yan X., Zeng Z., Tunici P., Ng H., and Abdulkair I.R. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 5 (2006) 67-75
63. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., and Jouvet A. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114 (2007) 97-109
64. Margareto J., Leis O., Larrarte E., Idoate M.A., Carrasco A., and Lafuente J.V. Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J. Mol. Neurosci. 32 1 (2007) 53-63
65. Martinho O., Longatto-Filho A., Lambros M.B., Martins A., Pinheiro C., Silva A., Pardal F., Amorim J., Mackay A., Milanezi F., Tamber N., Fenwick K., Ashworth A., Reis-Filho J.S., Lopes J.M., and Reis R.M. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. Br. J. Cancer 101 6 (2009) 973-982
66. Marumoto T., Tashiro A., Friedmann-Morvinsli D., Scadeng M., Soda Y., Gage F.H., and Verma I.M. Development of a novel mouse glioma model using lentiviral vectors. Nat. Med 15 1 (2009) 110-116
67. Mirzadeh Z., Merkle F.T., Soriano-Navarro M., Garcia-Verdugo J.M., and Alverez-Buylla A. Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell 3 (2008) 265-278
68. Molofsky, A.V., He, S., Bydon, M., Morrison, S.J., Pardal, R., 2005. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev. 19(12), 1432-1437.
69. Morrison S.J., Shah N.M., and Anderson D.J. Regulatory mechanisms review in stem cell biology. Cell (1997) 287-298
70. Murat A., Migliavacca E., Gorlia T., Lambiv W.L., Shay T., Hamou M.F., de Tribolet N., Regli L., Wick W., Kouwenhoven M.C., Hainfellner J.A., Heppner F.L., Dietrich P.Y., Zimmer Y., Cairncross J.G., Janzer R.C., Domany E., Delorenzi M., Stupp R., and Hegi M.E. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J. Clin. Oncol. 26 18 (2008 Jun 20) 3015-3024
71. Noble M., and Mayer-Proschel M. Growth factors, glia and gliomas. J. Neurooncol. 35 (1997) 193-209
72. Oda H., Zhang S., Tsurutani N., Shimizu S., Nakatsuru Y., Aizawa S., and Ishikawa T. Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. Cancer Res. 57 (1997) 646-650
73. Ogden A.T., Waziri A.E., and Lochhead R.A. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 62 (2008) 505-514
74. Ohgaki H., and Kleihues P. Genetic pathways to primary and secondary glioblastomas. Am. J. Pathol. 170 (2007) 1445-1453
75. Oliver T.G., Grasfeder L.L., Carroll A.L., Kaiser C., Gillingham C.L., Lin S.M., Wickramasinghe R., Scott M.P., and Wechsler-Reya R.J. Transcriptional profiling of the sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc. Natl. Acad. Sci. U. S. A. 100 12 (2003) 7331-7336
76. Pallini R., Ricci-Vitiani L., Banna G.L., Signore M., Lombardi D., Todaro M., Stassi G., Martini M., Maira G., Larocca L.M., and De Maria R. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin. Cancer Res. 15 (2008) 8205-8212
77. Paris D., Quadros A., Patel N., DelleDonne A., Humphrey J., and Mullan M. Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur. J. Pharmacol. 514 1 (2005) 1-15
78. Pevny L.H., and Nicolis S.K. Sox2 roles in neural stem cells. Int. J. Biochem. Cell Biol. (2009)
79. Philipp-Staheli J., Kim K.H., Liggitt D., Gurley K.E., Longton G., and Kemp C.J. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development. Oncogene 23 4 (2004) 905-913
80. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., Weissman I.L., Clarke M.F., and Ailles L.E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 973-978
81. Rebetz J., Tian D., Persson A., Widegren B., Salford L.G., Englund E., Gisselsson D., and Fan X. Glial progenitor-like phenotype in low grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma. PLoS One 3 (2008) e1936
82. Recht L., Jang T., Savarese T., and Litofsky N.S. Neural stem cells and neuro-oncology: quo vadis?. J. Cell Biochem. 88 (2003) 11-19
83. Reilly K.M., Loisel D.A., Bronson R.T., McLaughlin M.E., and Jacks T. Nf1;Tr p53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat. Genet. 26 (2000) 109-113
84. Reynolds B.A., Tetzlaff W., and Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 12 (1992) 4565-4574
85. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De Maria R. Identification and expression of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
86. Rosemblum M.L., Gerosa M., Dougherty D.V., Reese C., Barger G.R., Davis R.L., Levin V.A., and Wilson C.B. Age-related chemosensitivity of stem cells from human malignant brain tumors. Lancet 1 (1982) 885-887
87. Ruiz i Altaba A., Stecca B., and Sánchez P. Hedgehog-Gli signaling in brain tumors:stem cells and paradevelopmental programs in cancer. Cancer Lett. 204 2 (2004) 145-157
88. Salcman M. Survival in glioblastoma: historical perspective. Neurosurgery 7 (1980) 435-439
89. Salmaggi A., Boiardi A., Gelati M., Russo A., Calatozzolo C., Ciusani E., Sciacca F.L., Ottolina A., Parati E.A., La Porta C., Alessandri G., Marras C., Croci D., and De Rossi M. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54 8 (2006) 850-860
90. Schiffer D., Giordana M.T., Germano I., and Mauro A. Anaplasia and heterogeneity of GFAP expression in gliomas. Tumori 72 (1986) 163-170
91. Schmitz M., Temme A., Senner V., Ebner R., Schwind S., Stevanovic S., Wehner R., Schackert G., Schackert H.K., Fussel M., Bachmann M., Rieber E.P., and Weigle B. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br. J. Cancer 6 8 (2007) 1293-1301
92. Shih A.H., Dai C., Hu X., Rosenblum M.K., Koutcher J.A., and Holland E.C. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res. 64 14 (2004) 4783-4789
93. Shoshan Y., Nishiyama A., Chang A., Mork S., Barnett G.H., Cowell J.K., Trapp B.D., and Staugaitis S.M. Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10361-10366
94. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., and Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 63 18 (2003) 5821-5828
95. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
96. Soeda A., Inagaki A., Oka N., Ikegame Y., Aoki H., Yoshimura S., Nakashima S., Kunisada T., and Iwama T. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J. Biol. Chem. 283 16 (2008) 10958-10966
97. Stecca B., and Ruiz i Altaba A. Brain as a paradigm of organ growth: hedgehog-Gli signaling in neural stem cells and brain tumors. J. Neurobiol. 64 4 (2005) 476-490
98. Stewart L.A. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359 (2002) 1011-1018
99. Strojnik T., Røsland G.V., Sakariassen P.O., Kavalar R., and Lah T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg. Neurol. 68 2 (2007) 133-143
100. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., and Taphoorn M.J. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Eng. J. Med. 352 (2005) 987-996
101. Suh M.R., Lee Y., Kim J.Y., Kim S.K., Moon S.H., Lee J.Y., Cha K.Y., Chung H.M., Yoon H.S., Moon S.Y., Kim V.N., and Kim K.S. Human embryonic stem cells express a unique set of microRNAs. Dev. Biol. 270 2 (2004) 488-498
102. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
103. Tamaki S., Eckert K., He D., Sutton R., Doshe M., Jain G., Tushinski R., Reitsma M., Harris B., Tsukamoto A., Gage F., Weissman I., and Uchida N. Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J. Neurosci. Res. 69 (2002) 976-986
104. Tamiya T., Mizumatsu S., Ono Y., Abe T., Matsumoto K., Furuta T., and Ohmoto T. High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas. Acta Neuropathol. 101 4 (2001) 334-340
105. Thon N., Damianoff K., Hegermann J., Grau S., Krebs B., Schnell O., Tonn J.C., and Goldbrunner R. Presence of pluripotent CD133(+) cells correlates with malignancy of gliomas. Mol. Cell Neurosci. (2008)
106. Toda, M., Iizuka, Y., Yu, W., Imai, T., Ikeda, E., Yoshida, K., Kawase, T., Kawakami, Y., Okano, H., Uyemura, K., 2001. Expression of the neural RNA-binding protein Musashi1 in human gliomas. 34, 1-7.
107. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., and Weissman I.L. Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 14720-14725
108. Valk-Lingbeek M.E., Bruggeman S.W., and van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 118 4 (2004) 409-418
109. Wang J., Sakariassen P.O., and Tsinkakovsky O. CD133 negative glioma cells form tumors in nude rats and give raise to CD133 positive cells. Int. J. Cancer 122 (2008) 761-768
110. Wang J., Wang H., Li Z., Wu Q., Lathia J.D., McLendon R.E., Hjelmeland A.B., and Rich J.N. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One 3 11 (2008) e3769
111. Westphal M., Hilt D.C., Bortey E., Delvault P., Olivares R., and Warnke P.C. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary with malignant glioma. Neuro-Oncol. 5 (2003) 79-88
112. Wikstrand C.J., McLendon R.E., Friedman A.H., and Bigner D.D. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res. 57 (1997) 4130-4140
113. Xu Q., Yuan X., Liu G., Black K.L., and Yu J.S. Hedgehog signaling regulates brain tumor-initiating cell proliferation and portends shorter survival for patients with PTEN-coexpressing glioblastomas. Stem Cells 26 12 (2008) 3018-3026
114. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., and Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137 4 (2009) 647-658
115. Zaidi H.A., Kosztowski T., DiMeco F., and Quinones-Hinojosa A. Origins and clinical implications of the brain tumor stem cell hypothesis. J. Neurooncol. 93 (2009) 49-60
116. Zeppernick F., Ahmadi R., Campos B., Dictus C., Helmke B.M., Becker N., Lichter P., Unterberg A., Radlwimmer B., and Herold-Mende C.C. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 14 1 (2008) 123-129
117. Zhao X., D'Arca D., Lim W.K., Brahmachary M., Carro M.S., Ludwig T., Cardo C.C., Guillemot F., Aldape K., Califano A., Iavarone A., and Lasorella A. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in developing brain. Dev. Cell 17 (2009) 210-221
118. Zook B.C., Simmens S.J., and Jones R.V. Evaluation of ENU-induced gliomas in rats: nomenclature, immunochemistry, and malignancy. Toxicol. Pathol. 28 1 (2000) 193-201